Dr. Costas Lallas, MD

• Urology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Mayo Clinic Arizona

  Fellowship Hospital

• Duke University Medical Center

  Residency Hospital

• Duke University Medical Center

  Internship Hospital

• Thomas Jefferson University Sidney Kimmel Medical College

  Medical School, 1998

• Novel actions of next-generation taxanes benefit advanced stages of prostate cancer, 2015-02-15

• Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Patients With Adverse Pathologic Features Comparative Analysis of Long-term Outcomes, 2018-06-27

• Incidental Lymphoma Discovered During Surveillance for Low-Grade Upper Tract Urothelial Carcinoma Treated Ureteroscopically: A Case Report Series, 2016-02-01

• Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer, 2020-02-03

• PHARMACOLOGICAL INHIBITION OF JAK2-STAT5 SIGNALING BY JAK2 INHIBITOR AZD1480 POTENTLY SUPPRESSES GROWTH OF BOTH PRIMARY AND CASTRATE-RESISTANT PROSTATE CANCER, 2013-08-13

• Identifying Barriers to Patient Acceptance of Active Surveillance: Content Analysis of Online Patient Communications, 2013-09-11

• Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy, 2011-05-24

• Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy, 2014-07-08

• Patient Factors Impacting Perioperative Outcomes for T1b-T2 Localized Renal Cell Carcinoma May Guide Decision for Partial versus Radical Nephrectomy, 2022-12-26

• Pleiotropic impact of DNA-PK in cancer and implications for therapeutic strategies, 2019-07-02

• A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA, 2014-09-07

• Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response, 2018-06-06

• Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy, 2019-11-12

• PARP-1 regulates DNA repair factor availability, 2018-11-22

• Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience, 2015-04-08

• Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer, 2020-03-10

• Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer, 2015-08-01

• Structure-based screen identifies a potent small-molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia, 2015-05-29

• Hematologic toxicity of concurrent administration of Radium-223 and next generation anti-androgen therapies, 2015-01-23